39 related articles for article (PubMed ID: 10629586)
1. Investigating the key membrane protein changes during in vitro erythropoiesis of protein 4.2 (-) cells (mutations Chartres 1 and 2).
van den Akker E; Satchwell TJ; Pellegrin S; Flatt JF; Maigre M; Daniels G; Delaunay J; Bruce LJ; Toye AM
Haematologica; 2010 Aug; 95(8):1278-86. PubMed ID: 20179084
[TBL] [Abstract][Full Text] [Related]
2. Complications of Evans' syndrome in an infant with hereditary spherocytosis: a case report.
Yoshida H; Ishida H; Yoshihara T; Oyamada T; Kuwana M; Imamura T; Morimoto A
J Hematol Oncol; 2009 Sep; 2():40. PubMed ID: 19740448
[TBL] [Abstract][Full Text] [Related]
3. The use of real-time PCR technique in the detection of novel protein 4.2 gene mutations that coexist with thalassaemia alpha in a single patient.
Maciag M; Adamowicz-Salach A; Siwicka A; Spychalska J; Burzynska B
Eur J Haematol; 2009 Oct; 83(4):373-7. PubMed ID: 19508687
[TBL] [Abstract][Full Text] [Related]
4. Human Rhesus-associated glycoprotein mediates facilitated transport of NH(3) into red blood cells.
Ripoche P; Bertrand O; Gane P; Birkenmeier C; Colin Y; Cartron JP
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17222-7. PubMed ID: 15572441
[TBL] [Abstract][Full Text] [Related]
5. Characteristic features of the genotype and phenotype of hereditary spherocytosis in the Japanese population.
Yawata Y; Kanzaki A; Yawata A; Doerfler W; Ozcan R; Eber SW
Int J Hematol; 2000 Feb; 71(2):118-35. PubMed ID: 10745622
[TBL] [Abstract][Full Text] [Related]
6. Co-existence of hereditary spherocytosis and a new red cell pyruvate kinase variant: PK mallorca.
Zarza R; Moscardó M; Alvarez R; García J; Morey M; Pujades A; Vives-Corrons JL
Haematologica; 2000 Mar; 85(3):227-32. PubMed ID: 10702808
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of hereditary elliptocytosis and hereditary spherocytosis.
Delaunay J; Alloisio N; Morle L; Baklouti F; Dalla Venezia N; Maillet P; Wilmotte R
Ann Genet; 1996; 39(4):209-21. PubMed ID: 9037349
[TBL] [Abstract][Full Text] [Related]
8. Heavy transfusions and presence of an anti-protein 4.2 antibody in 4. 2(-) hereditary spherocytosis (949delG).
Beauchamp-Nicoud A; Morle L; Lutz HU; Stammler P; Agulles O; Petermann-Khder R; Iolascon A; Perrotta S; Cynober T; Tchernia G; Delaunay J; Baudin-Creuza V
Haematologica; 2000 Jan; 85(1):19-24. PubMed ID: 10629586
[TBL] [Abstract][Full Text] [Related]
9. Hematologically important mutations: band 3 and protein 4.2 variants in hereditary spherocytosis.
Gallagher PG; Forget BG
Blood Cells Mol Dis; 1997 Dec; 23(3):417-21. PubMed ID: 9446757
[No Abstract] [Full Text] [Related]
10. [Molecular mechanism of hereditary spherocytosis].
Bogusławska DM; Heger E; Sikorski AF
Pol Merkur Lekarski; 2006 Jan; 20(115):112-6. PubMed ID: 16617750
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
